Care home visiting

Visiting restrictions for care homes in England have been relaxed by the government as the Covid omicron wave has begun to pass.

Since Monday (31 January) there has been no limit on numbers of visitors and self-isolation periods for residents who test positive have been cut from 14 days to 10 days with further reductions for those testing negative on days 5 and 6.

Care workers are no longer required to take weekly PCR tests but are asked to take lateral flow tests before their shifts instead.

The easing of visiting restrictions came as 86.5% of all care home residents had had their booster jab, shown to be 92% effective in preventing hospitalisation.

Care minister Gillian Keegan said unlimited visits would now be allowed.  “The changes announced today are backed by scientists, ensuring we all have more freedoms from coronavirus, including care home residents and their families.”

But Nadra Ahmed, chair of the National Care Association, warned that the lifting of restrictions would be tricky for care providers.

“This will come with some challenges because the virus is still out there and we also know that up to 50% of services are in outbreak at this moment in time,” she told the BBC last week.

“It is about that safety and the responsibility that is on the provider to make it all happen and keep everybody safe.  Those are the worries that we would have.”

Similar Posts

  • ‘AI in Adult Social Care’ guidance published 

    The Digitising Social Care programme has published guidance for adult social care providers on using Artificial Intelligence (AI).  The guidance, entitled ‘AI in Adult Social Care’, was developed by the Digital Care Hub who consulted with care provides to ensure their views and experiences were incorporated. The guidance explores how AI is being integrated into…

  • ADI 2024 in Krakow

    Alzheimer’s Disease International (ADI) has put out a call for abstracts for presentations at its annual conference in Krakow, Poland, in 2024. ADI’s 36th Global Conference runs from 24-26 April and is subtitled “Dementia: Insights, Innovations and Inspirations.” Both scientific and non-scientific abstracts are welcomed around the seven action areas of the World Health Organisation…

  • New drug announced

    Just a few months after the announcement of lecanemab as a drug for slowing Alzheimer’s progression, a second new drug has been announced by pharmaceutical firm Eli Lilly.  Called donanemab, it is also a monoclonal antibody drug for removing amyloid protein that builds up in the brain as Alzheimer’s disease progresses.  In people with mild…

  • Local heroes:

    A pioneering gift card scheme rewarded 1,000 family carers across Scotland during Carers Week this month.  The gift cards are part of the Scotland Loves Local campaign to support local economies and can only be spent in the areas where they are issued.  Scotland’s Towns Partnership interim chief office Kimberley Guthrie, who manages the scheme…